We believe in – and have seen firsthand many times over – the power of innovation to positively transform health and well-being. That’s why we actively support research and development into scientific breakthroughs that can help solve the world’s most challenging problems.
Dr. Mike McCune, head of the foundation’s HIV Frontiers Program, details a groundbreaking new partnership with Novartis to develop affordable, single-dose gene therapies for people infected with sickle cell disease…
Andrew Trister, deputy director of Digital Health and Innovation at the Bill & Melinda Gates Foundation, shares how programmers and technologists are developing tools that track and test for COVID-19.
Trevor Mundel provides an update on the COVID-19 Therapeutics Accelerator’s progress in research, manufacturing, and testing. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of…
Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the…
Dr. Toni Hoover, director of Strategy, Planning, and Management for Global Health at the Gates Foundation, shares what the CoVig Alliance means for the wider fight against COVID-19—and the foundation’s…
CEO Mark Suzman reflects on the foundation’s unique position to respond to the COVID-19 crisis and shares an update on the foundation’s more than $250 million commitment to funding response…
Trevor Mundel, who leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries, discusses the first trials funded through the Therapeutics…
Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
